|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1050 GBX | -4.55% |
|
+5.00% | -51.16% |
| 06:36am | WINNERS & LOSERS: Beauty Tech ups guidance; Ixico to beat expectations | AN |
| 07-02 | WINNERS & LOSERS: Capricorn jumps after agreeing to Genel takeover | AN |
| Market Cap | 5.52M 6.3M 5.08M 4.72M 8.96M 601M 9.08M 60.87M 23.69M 295M 23.67M 23.15M 1.02B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 10.38M 11.86M 9.56M 8.88M 16.86M 1.13B 17.08M 114M 44.55M 555M 44.52M 43.54M 1.92B | EV / Sales 2026 * |
5.59x | EV / Sales 2027 * | - |
| Free-Float |
90.13% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Oxford BioDynamics Plc
| 1 day | -4.55% | ||
| 1 week | +5.00% | ||
| Current month | +5.00% | ||
| 1 month | -44.74% | ||
| 3 months | -46.15% | ||
| 6 months | -55.32% | ||
| Current year | -51.16% |
| 1 week | 0.08 |  | 0.12 |
| 1 month | 0.08 | | 0.2 |
| Current year | 0.08 | | 0.34 |
| 1 year | 0.08 | | 0.78 |
| 3 years | 0.08 | | 52 |
| 5 years | 0.08 | | 62.8 |
| 10 years | 0.08 | | 278.82 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | 64 | 2007-06-07 | |
Richard Compton
CEO | Chief Executive Officer | - | 2026-06-29 |
Paul Stockdale
DFI | Director of Finance/CFO | - | 2017-09-14 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 64 | 2007-06-07 | |
Paul Stockdale
BRD | Director/Board Member | - | 2017-09-14 |
David Holbrook
BRD | Director/Board Member | 65 | 2019-04-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11-09 | Free | Founder | 15,000,000 | 0.7663% | ||
| 11-09 | Free | Chairman | 4,400,000 | 0.2248% | ||
| 11-09 | Free | Executive/Senior Manager | 15,000,000 | 0.7663% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.55% | +5.00% | -59.62% | -99.19% | 6.3M | |
| +6.87% | +7.31% | -9.54% | -19.57% | 3.31B | |
| +1.67% | +8.96% | +13.05% | -82.04% | 2.02B | |
| -0.11% | +3.55% | -6.97% | -3.51% | 309M | |
| -0.40% | -1.98% | -44.02% | - | 51.97M | |
| Average | +0.67% | -1.06% | -21.42% | -51.08% | 1.14B | |
| Weighted average by Cap. | +4.54% | +10.24% | -1.75% | -41.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.86M 2.12M 1.71M 1.59M 3.01M 202M 3.05M 20.46M 7.96M 99.23M 7.96M 7.78M 344M | - |
| Net income | - | - |
| Net Debt | 4.86M 5.55M 4.48M 4.16M 7.89M 530M 8M 53.61M 20.86M 260M 20.85M 20.39M 901M | - |
Employees
37
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-07 | GBX 0.1050 | -4.55% | 32,683,096 |
| 26-07-06 | GBX 0.1100 | 0.00% | 19,916,375 |
| 26-07-03 | GBX 0.1100 | +22.22% | 18,279,976 |
| 26-07-02 | GBX 0.0900 | -5.26% | 41,618,070 |
| 26-07-01 | GBX 0.0950 | -5.00% | 61,845,284 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.001100GBP
Average target price
0.0100GBP
Spread / Average Target
+809.09%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- OBD Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
